Zannas, Anthony S.
Published in
Dialogues in Clinical Neuroscience
Psychosocial stress—especially when chronic, excessive, or occurring early in life—has been associated with accelerated aging and increased disease risk. With rapid aging of the world population, the need to elucidate the underlying mechanisms is pressing, now more so than ever. Among molecular mechanisms linking stress and aging, the present artic...
Nestler, Eric J.
Published in
Dialogues in Clinical Neuroscience
Depression is a devastating psychiatric disorder caused by a combination of genetic predisposition and life events, mainly exposure to stress. Early life stress (ELS) in particular is known to “scar” the brain, leading to an increased susceptibility to developing depression later in life via epigenetic mechanisms. Epigenetic processes lead to chang...
Thibaut, Florence
Published in
Dialogues in Clinical Neuroscience
Most studies describing epigenetic modifications have focused on DNA methylation, but fewer studies have focused on histone modifications and noncoding RNAs. Chromatin architecture and CCCTC-binding factor represent important noncoding regulatory elements that warrant further investigation in order to improve our understanding of the genomic basis ...
Ressler, Kerry J.
Published in
Dialogues in Clinical Neuroscience
Post-traumatic stress disorder (PTSD) is a syndrome which serves as a classic example of psychiatric disorders that result from the intersection of nature and nurture, or gene and environment. By definition, PTSD requires the experience of a traumatic exposure, and yet data suggest that the risk for PTSD in the aftermath of trauma also has a herita...
Binder, Elisabeth B.
Published in
Dialogues in Clinical Neuroscience
The risk for major depression is both genetically and environmentally determined. It has been proposed that epigenetic mechanisms could mediate the lasting increases in depression risk following exposure to adverse life events and provide a mechanistic framework within which genetic and environmental factors can be integrated. Epigenetics refers to...
Day, Jeremy J.
Published in
Dialogues in Clinical Neuroscience
Numerous neuronal functions depend on the precise spatiotemporal regulation of gene expression, and the cellular machinery that contributes to this regulation is frequently disrupted in neurodevelopmental, neuropsychiatric, and neurological disease states. Recent advances in gene editing technology have enabled increasingly rapid understanding of g...
Szyf, Moshe
Published in
Dialogues in Clinical Neuroscience
Early life adversity is associated with long-term effects on physical and mental health later in life, but the mechanisms are yet unclear. Epigenetic mechanisms program cell-type-specific gene expression during development, enabling one genome to be programmed in many ways, resulting in diverse stable profiles of gene expression in different cells ...
Akbarian, Schahram
Published in
Dialogues in Clinical Neuroscience
Schizophrenia is a debilitating psychiatric disorder with a complex genetic architecture and limited understanding of its neuropathology, reflected by the lack of diagnostic measures and effective pharmacological treatments. Geneticists have recently identified more than 145 risk loci comprising hundreds of common variants of small effect sizes, mo...
Kenny, Paul J.
Published in
Dialogues in Clinical Neuroscience
Drugs of abuse can modify gene expression in brain reward and motivation centers, which contribute to the structural and functional remodeling of these circuits that impacts the emergence of a state of addiction. Our understanding of how addictive drugs induce transcriptomic plasticity in addiction-relevant brain regions, particularly in the striat...
Verdejo-Garcia, Antonio Garcia-Fernandez, Gloria Dom, Geert
Published in
Dialogues in clinical neuroscience
Nous résumons dans cet article ciblé les connaissances actuelles sur les troubles cognitifs liés à l’utilisation d’une substance (TUS), sur le lien entre ces troubles et les résultats cliniques, sur l’entraînement cognitif, la remédiation cognitive et les traitements pharmacologiques qui peuvent aider la cognition. Nos conclusions sont les suivante...